Zhixin Finance APP News, Shen Zhen Weiguang Biological Products (002880.SZ) released its 2024 interim report, with revenue of 0.523 billion yuan, a year-on-year increase of 14.38%. The net income attributable to the shareholders of the listed company was 0.11 billion yuan, an increase of 8.75% year-on-year. The net profit attributable to the shareholders of the listed company after deducting non-recurring gains and losses was 0.108 billion yuan, an increase of 8.34% year-on-year. The basic earnings per share was 0.4844 yuan.